Citations

Institution: Mayo Clinic Clear

Showing 10 of 108119 citations.

Pomalidomide: A Step on the PATH Forward for Treatment of Hereditary Hemorrhagic Telangiectasia
Wolf, Emily, Wysokinska, Ewa , Shah, Surbhi

The Hematologist | April 18, 2025 | Volume: 22 | Issue: 3 | Pages: No page available

10.1182/hem.v22.3.202535 Get It

Challenges in Automating Extraction of Real-World Radiographic Images and Adverse Events: Lessons From the ICAREdata Initiative
Piantadosi, Steven , Campbell, Nancy , Chow, Selina , Elrahi, Cassandra , Knopp, Michael V. , Kumar, Vaibhav , Lerro, Catherine C. , Rivera, Donna R. , Quina, Andre , Casagni, Michelle , Mohammed-Rajput, Nareesa, Casagni, Michelle , Mohammed-Rajput, Nareesa , Tevaarwerk, Amye J , George, Suzanne , Chow, Selina , Kluetz, Paul Gustav , Tevaarwerk, Amyé , George, Suzanne

JCO Clinical Cancer Informatics | April 18, 2025 | Volume: No volume available | Issue: 9 | Pages: No page available

10.1200/cci-24-00319 | PMID 40249879 Get It

Germline Genetic Variants in Cancer Predisposition Genes in Patients From Latin America and the Caribbean
Wegman-Ostrosky, Talía , Zatarain-Barrón, Zyanya Lucía , Trejo‐Becerril, Catalina , Ramírez-González, Alfredo , Romo-Huerta, Jimena, Rodríguez, Lisa , Espino-Gutiérrez, Isabel, Vilchis-Zapata, Z.H., Harari-Arakindji, Sylvia, Ruíz-Patiño, Alejandro , Taja-Chayeb, Lucia , Barron, Lucia Zatarain , Trejo-Becerril, Catalina , Ramirez-Gonzalez, Alfredo , Rodriguez-Rojas, Lisa Ximena , Espino-Gutiérrez, Isabel , Harari-Arakindji, Sylvia , García-Ortiz, José Elías , Ruíz-Patiño, Alejandro

JCO Global Oncology | April 18, 2025 | Volume: No volume available | Issue: 11 | Pages: No page available

10.1200/go-24-00433 | PMID 40249889 Get It

The importance of having region-specific data when planning health interventions has become evident in recent years. Nonetheless, several world regions, including Latin America and the Caribbean (LAC), still face significant challenges. These regions need to develop strategies specifically designed to consider the inherent characteristics of their population composite and sociodemographic characteristics. More than 20% of the global cancer incidence arises in LAC. Yet, treatment, prevention, and follow-up guidelines in the area are frequently based on studies that mainly include patients from North America, Europe, and Asia. As personalized approaches become ubiquitous in medical practice, the amount of information emerging from LAC has risen considerably. In this review, we seek to present a comprehensive summary of the frequency of germline genetic variants in hereditary cancer syndromes in patients from LAC. The data highlight relevant differences in variants associated with LAC patients, including founder and recurrent variants, while showcasing potential features that might be relevant in oncology practices.
Sustained mTORC1 activation in activated T cells impairs vaccine responses in older individuals
Lin, Xiaorong , Du, Yanhua , Kan, Shuo , Chen, Junjie , Yin, Yunxue, Li, Linlin , Jiang, Wuhua , Cao, Wenqiang , Kim, Chulwoo , Chen, Liang , Wang, Shiwen , Goronzy, Jörg J. , Jin, Jun , Jiang, Wenrong , Cao, Wenqiang , Kim, Chulwoo , Chen, Liang , Wang, Shiwen , Jin, Jun , Goronzy, Jorg , Lin, Xiaorong , Du, Yanhua , Li, Linlin, Chen, Jingwen, Chen, Jingwen

Science Advances | April 18, 2025 | Volume: 11 | Issue: 16 | Pages: No page available

10.1126/sciadv.adt4881 | PMID 40249803 Get It

T cell aging contributes to the lower vaccine efficacy in older adults, yet the molecular mechanism remains elusive. Here, we show the density of initially responding naïve CD4 + T cells is instructive in T follicular helper (TFH) cell fate decisions and declines with age. A lower number of initially responding cells did not affect TFH differentiation at peak responses after immunization but accounted for an increased contraction phase manifesting as a larger loss of CXCR5 expression. Mechanistically, cells activated at a lower initial density had more sustained mammalian target of rapamycin complex 1 (mTORC1) activities that impair CXCR5 maintenance. YAP-dependent regulation of SLC7A5 involved in the cell density–dependent regulation of mTORC1 activities and TFH loss. Old mice fed with a leucine-restricted diet after peak responses showed smaller TFH loss and improved humoral immune responses. Attenuating mTORC1 signaling after peak response is a strategy to boost vaccine responses in older individuals.
Delayed T-cell recovery after hematopoietic cell transplantation is associated with decreased overall survival in adults
Perales, Miguel‐Angel , Riches, Marcie , He, Naya, Chemaly, Roy F. , Dandoy, Christopher E. , Hill, Joshua A. , Díaz, Miguel Ángel , Hashmi, Shahrukh K. , Prockop, Susan E. , Hildebrandt, Gerhard , Szabolcs, Paul , Hill, Joshua A. , Martens, Michael J , Chemaly, Roy F , Dandoy, Christopher E , Hill, Joshua A , Diaz Perez, Miguel Angel , Hashmi, Shahrukh K , Prockop, Susan E , Lazarus, Hillard M , Auletta, Jeffery J , Szabolcs, Paul , Perales, Miguel-Angel , Hill, Joshua A , Martens, Michael J. , Lazarus, Hillard M. , Beitinjaneh, Amer , Auletta, Jeffery J.

Blood Advances | April 18, 2025 | Volume: 9 | Issue: 14 | Pages: 3502-3517

10.1182/bloodadvances.2024015288 | PMID 40249911 Get It

Abstract Allogeneic hematopoietic cell transplantation (allo-HCT) can provide curative treatment for hematologic malignancies but is associated with prolonged lymphopenia that may contribute to an increased risk of infection and relapse, resulting in decreased survival. We hypothesized that patients with rapid and robust CD4 T- and B-cell recovery have improved survival and decreased treatment-related mortality (TRM). A total of 2089 patients were included who underwent first allo-HCT for acute myeloid leukemia/acute lymphoblastic leukemia/myelodysplastic syndrome from 2008 to 2019 reported to the Center for International Blood and Marrow Transplant Research with available CD4 counts at days 100 and 180. Patients (median age, 51 years [range, 2-75]) were categorized into 4 groups based on graft-versus-host disease (GVHD) prophylaxis: ex vivo T-cell depletion (TCD/CD34), posttransplant cyclophosphamide, calcineurin inhibitor alone (CNI), or CNI with antithymocyte globulin. Based upon survival, we could identify optimal cutoff points for CD4+ T cells in pediatric (age of <20 years) patients: 248 × 106/L and 420 × 106/L at days 100 and 180, respectively; and in adult (age of >20 years) patients: 104 × 106/L and 115 × 106/L at days 100 and 180, respectively. In adults, day-100 CD4 count was associated with overall survival (OS), progression-free survival (PFS), and TRM but not relapse, incidence of infections, or chronic GVHD. Similarly, CD4 counts above the cutoff point at day 180 in adults were associated with improved OS, PFS, and TRM but no other outcomes. No clinical associations for CD4 counts were identifiable in pediatric patients. These findings underscore the importance of tailoring transplant strategies for adults to optimize immune recovery and improve patient outcomes.
Child Sexual Abuse Module in the Child Abuse Pediatrics Curriculum for Physicians (CAP-CuP)
Bangash, Maheen, Crumm, Caitlin E. , Brown, Emily , Petska, Hillary W., Frank, Lauren R., Sheets, Lynn K. , Johnson, Katie L. , Bangash, Maheen K

MedEdPORTAL | April 18, 2025 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.15766/mep_2374-8265.11515 | PMID 40255580 Get It

Early Postpartum Pelvic Floor Muscle Training With Transabdominal Ultrasound Imaging
Ron, Nicole J., Hill, Lauren H., Hahn, Kathleen M., Carlson, Anna M., Howden, Jenna G., Pennell, Taylor N., Rowenhorst, Rachel J., Ron, Eyal D. , Hill, Lauren H., Hahn, Kathleen M., Carlson, Anna M., Howden, Jenna G., Hollman, John H.

Journal of Women's & Pelvic Health Physical Therapy | April 18, 2025 | Volume: 49 | Issue: 2 | Pages: 55-63

10.1097/jwh.0000000000000324 Get It

Purpose: This study examined if vertical bladder excursion during pelvic floor muscle (PFM) contraction, measured with transabdominal ultrasound (TAUS), improved following a single training session 0-5 days postpartum. It also assessed patient satisfaction with the training. Methods: 75 healthy, female volunteers within 0-5 days post-vaginal delivery were recruited during their inpatient postpartum stay. Participants completed one in-person session involving a standardized bladder filling protocol, TAUS imaging during PFM contractions, a PFM training session using TAUS as visual biofeedback, and a two-question post intervention survey. Vertical bladder base excursions were compared pre- and post- training between two groups: those whose bladder bases descended and those whose ascended during baseline contractions. A mixed model ANOVA with one between-group factor (baseline descenders vs. ascenders) and one within-group factor (pre- vs. post-training) analyzed the change in bladder lift. Patient satisfaction was assessed with Likert scales. Results: Mean vertical excursion increased from 0.12 cm (SD = 0.48) to 0.32 cm (SD = 0.33) post-training, which was statistically significant (p <.001, Cohens d = 0.767). Greater improvements were noted in those with a bladder base descent at baseline. All participants reported the experience to be helpful or very helpful and were satisfied or very satisfied. Discussion: Participants increased vertical bladder excursion during PFM contraction with TAUS biofeedback within a single session, especially those with baseline paradoxical bladder excursion and perineal trauma during delivery. Participants found the experience helpful and satisfying, suggesting TAUS biofeedback may be a useful tool in early postpartum PFM rehabilitation.
Genetics of morphological hip abnormalities and their implications for osteoarthritis: a scoping review
Bukowiec, Lainey G , Kaji, Elizabeth S, Koch, John A, Saniei, Sami , Girod-Hoffmann, Miguel M, Wyles, Cody C. , Wyles, Cody C , Kaji, Ellie , Koch, John A, Sinnwell, Jason P.

Journal of Hip Preservation Surgery | April 18, 2025 | Volume: 12 | Issue: 3 | Pages: 202-216

10.1093/jhps/hnaf020 | PMID 41019141 Get It

Abstract Morphological hip abnormalities (MHAs) significantly influence lifelong prognosis of the hip, contributing to early-onset osteoarthritis and impaired functionality. Developmental dysplasia of the hip (DDH) and femoroacetabular impingement (FAI) represent key pathologies, resulting from insufficient or excessive femoral head coverage, respectively. These abnormalities alter hip biomechanics, leading to structural damage, pain, and accelerated joint degeneration. Advances in genetic research have illuminated the interplay between genetics and mechanical loading in shaping hip morphology. Genes associated with osteoarthritis, DDH, and FAI include COL1A1, MMP13, and IL-6. Genes associated with FAI and osteoarthritis include ADAMTS4. Genes associated with DDH and osteoarthritis include FRZB, CX3CR1, ASPN, DKK1, PDRG1, GDF5, UQCC1, and TGF-β1. The mechanisms linking morphological derangements to symptomatic osteoarthritis remain incompletely understood. Multimodal approaches integrating imaging, biomechanics, and genetics may uncover distinct disease subtypes, enabling personalized interventions. Early detection of MHAs is critical in preventing early-onset osteoarthritis. Incorporating advanced imaging techniques, such as statistical shape modelling, can enhance the understanding of complex 3D hip morphologies and their progression to osteoarthritis. Future research should explore the genetic underpinnings of other morphologic hip conditions, including Slipped Capital Femoral Epiphysis and Legg–Calvé–Perthes disease, to refine preventive and therapeutic strategies. A comprehensive approach combining genetics, imaging, and clinical insights holds promise for mitigating the lifelong impact of MHAs.
Response to negative pressure wound therapy for infection control
Provenzano, David , Hunt, Christine , Pilitsis, Julie G. , Provenzano, David Anthony , Hunt, Christine , Narouze, Samer

Regional Anesthesia & Pain Medicine | April 18, 2025 | Volume: No volume available | Issue: No issue available | Pages: rapm-2025-106663

10.1136/rapm-2025-106663 | PMID 40250978 Get It

ASRA Pain Medicine narrative review and expert practice recommendations for gastric point-of-care ultrasound to assess aspiration risk in medically complex patients undergoing regional anesthesia and pain procedures
Haskins, Stephen C. , Ledbetter, Leila , Arzola, Cristián , Hardman, H. David , Panzer, Oliver, Weber, Marissa M, Heinz, Eric , Boublik, Jan , Cubillos, Javier , Hernandez, Nadia , Zimmerman, Joshua , Perlas, Anahi , Arzola, Cristian , Hardman, David , Boublik, Jan , Cubillos, Javier , Perlas, Anahi , Bronshteyn, Yuriy S. , Kalagara, Hari , Weber, Marissa M

Regional Anesthesia & Pain Medicine | April 18, 2025 | Volume: 51 | Issue: 7 | Pages: 723-745

10.1136/rapm-2024-106346 | PMID 40250977 Get It

Gastric point-of-care ultrasound (POCUS) may offer clinical value in assessing aspiration risk among medically complex patients undergoing regional anesthesia and pain procedures. While the American Society of Anesthesiologists (ASA) preoperative fasting guidelines primarily apply to healthy individuals, medically complex populations often present with differing gastric emptying and aspiration risk. This narrative review, conducted by the American Society of Regional Anesthesia and Pain Medicine (ASRA-PM), adhered to PRISMA guidelines and was registered with PROSPERO. It focused on seven medically complex patient groups: those who are pregnant, obese, diabetic, have gastroesophageal reflux disease (GERD), are receiving emergency care, are enterally fed, or are taking GLP-1 receptor agonists (GLP-1RA). Study quality was assessed using the Mixed Methods Appraisal Tool (MMAT). Practice recommendations were developed using an iterative expert consensus process, with final recommendations based on evidence strength, clinical relevance, and expert agreement. Findings support the use of gastric POCUS in patients in active labor, those undergoing urgent cesarean sections, and those with diabetes. Conditional support is given for obesity, emergency care, enteral feeding, and GLP-1RA use. Routine use is not recommended in non-laboring pregnancies, elective cesarean delivery, or GERD. While gastric POCUS may aid with aspiration risk evaluation, its use should complement clinical judgment. Implementation may be limited by practical and training constraints, requiring individualized decision-making. These recommendations serve as a foundation for future research and potential clinical guideline development. PROSPERO registration number: CRD42023445927.